Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Full Paper
  • Published:

The EIF2AK3 gene region and type I diabetes in subjects from South India

Genes & Immunity volume 5, pages 648–652 (2004)Cite this article

Abstract

Mutations in the EIF2AK3 gene underlie susceptibility to the Wolcott–Rallison syndrome, which is a monogenic disease associated with insulin-deficient neonatal diabetes. Furthermore, suggestive evidence of linkage between type 1 diabetes (T1DM) and the EIF2KA3 chromosomal region has been reported in Scandinavian families. We have investigated the hypothesis that polymorphic variants in and around the EIF2AK3 gene might partially account for susceptibility to T1DM in South Indian subjects. Excess transmission of the common alleles of two polymorphic markers (D2S1786 and 15INDEL, located within the gene) downstream of EIF2AK3, either singly (D2S1786, P=0.01) and 15INDEL (P=0.02) or as a combination (P<0.001), were found in 234 families with a T1DM proband. There was also a clear paternal effect for the 15INDEL marker (P=0.005) on disease susceptibility. The presence of the common allele of both markers was found in decreased frequency in the subjects with normal glucose tolerance compared to probands with T1DM (both P⩽0.0001). Major common mutations of the EIF2AK3 gene in T1DM were excluded. In conclusion, this pilot study demonstrates an association between the region around the EIF2AK3 locus and T1DM susceptibility.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Pociot F, McDermott MF . Genetics of Type 1 diabetes mellitus. Genes Immun 2002; 3: 235–249.

    Article  CAS  Google Scholar 

  2. Ramachandran A, Snehalatha C, Tuomilehto-Wolf E . Type 1 diabetes in the offspring does not increase the risk of parental Type 2 diabetes in South Indians. Diabetes Metab Res Rev 1999; 15: 328–331.

    Article  CAS  Google Scholar 

  3. Kambo PK, Hitman GA, Mohan V et al. The genetic predisposition to fibrocalculous pancreatic diabetes. Diabetologia 1989; 32: 45–51.

    Article  CAS  Google Scholar 

  4. Wolcott CD, Rallison MV . Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972; 80: 292–297.

    Article  CAS  Google Scholar 

  5. Senee V, Vattem KM, Delepine M, Rainbow LA, Haton C, Lecoq A . Wolcott–Rallison syndrome. Clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004; 53: 1876–1883.

    Article  CAS  Google Scholar 

  6. Thornton CM, Carson DJ, Stewart FJ . Autopsy findings in the Wolcott–Rallison syndrome. Pediatr Pathol Lab Med 1997; 17: 487–496.

    Article  CAS  Google Scholar 

  7. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C . EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott–Rallison syndrome. Nat Genet 2000; 25: 406–409.

    Article  CAS  Google Scholar 

  8. Castelnau P, Le Merrer M, Diatloff-Zito C, Marquis E, Tete MJ, Robert JJ . Wolcott–Rallison syndrome: a case with endocrine and exocrine pancreatic deficiency and pancreatic hypotrophy. Eur J Pediatr 2000; 159: 631–633.

    Article  CAS  Google Scholar 

  9. Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle E . Loss of kinase activity in a patient with Wolcott–Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes 2002; 51: 2301–2305.

    Article  CAS  Google Scholar 

  10. Brickwood S, Bonthron DT, Al-Gazali LI et al. Wolcott–Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet 2003; 40: 685–689.

    Article  CAS  Google Scholar 

  11. European Consortium for IDDM Genome Studies. A genomewide scan for Type-1 diabetes susceptibility in Scandinavian families: identification of new loci with evidence of interactions. Am J Hum Genet 2001; 69: 1301–1313.

  12. Ramachandran A, Snehalatha C, Dharmaraj D, Viswanathan M . Prevalence of glucose intolerance in Asian Indians. Urban–rural difference and significance of upper body adiposity. Diab Care 1992; 15: 1348–1355.

    Article  CAS  Google Scholar 

  13. Xie X, Ott J . Testing linkage disequilibrium between a disease gene and marker loci. Am J Hum Genet 1993; 53: 1107.

    Google Scholar 

  14. Zhao JH, Curtis D, Sham PC . Model-free analysis and permutation test for allelic associations. Hum Hered 2000; 50: 133–139.

    Article  CAS  Google Scholar 

  15. Shi Y, An J, Liang J et al. Characterization of a mutant pancreatic eIF-2α kinase, PEK, and co-localization with somatostatin in islet delta cells. J Biol Chem 1999; 274: 5723–5730.

    Article  CAS  Google Scholar 

  16. Kaufman RJ . Stress signalling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999; 13: 1211–1233.

    Article  CAS  Google Scholar 

  17. Harding HP, Zeng H, Zhang Y et al. Diabetes mellitus and exocrine pancreatic dysfunction in Perk-I-mice reveals a role for translational control in secretory cell survival. Molec Cell 2001; 7: 1153–1163.

    Article  CAS  Google Scholar 

  18. Vaxillaire M, Benmezroua Y, Durand E, Vasseur F, Froguel P . No evidence for diabetes-associated mutations of PEK/EIF2AK3 gene in French patients with early-onset type II diabetes. Diabetologia 2001; 44: 786.

    Article  CAS  Google Scholar 

  19. Nickerson DA, Tobe VO, Taylor SL . PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997; 25: 2745–2751.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Grant support was provided by the Juvenile Diabetes Research Foundation International (Grant number 1-1999-691) and Diabetes UK.

Author information

Authors and Affiliations

  1. Centre for Diabetes and Metabolic Medicine and the Genome Centre, Barts and the London Queen Mary's School of Medicine and Dentistry, University of London, UK

    R A Allotey, M F McDermott, Z Hassan, P G Cassell, B V North, M Vaxillaire, C A Mein, D C Swan, E O'Grady, P Froguel & G A Hitman

  2. Madras Diabetes Research Foundation, Chennai, India

    V Mohan, R Deepa & G Premalatha

  3. Diabetes Research Centre, Chennai, India

    A Ramachandran & C Snehalatha

  4. Department of Immunopathology, Tissue Typing Unit, Royal London Hospital, Barts and the London NHS Trust, London, UK

    P J Sinnot & S K Hemmatpour

Authors
  1. R A Allotey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. V Mohan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M F McDermott
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Deepa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Premalatha
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Z Hassan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P G Cassell
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. B V North
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Vaxillaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. C A Mein
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. D C Swan
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. E O'Grady
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. A Ramachandran
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. C Snehalatha
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. P J Sinnot
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. S K Hemmatpour
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. P Froguel
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. G A Hitman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G A Hitman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allotey, R., Mohan, V., McDermott, M. et al. The EIF2AK3 gene region and type I diabetes in subjects from South India. Genes Immun 5, 648–652 (2004). https://doi.org/10.1038/sj.gene.6364139

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gene.6364139

Keywords

This article is cited by

Search

Advanced search

Quick links